Zurueck zur Suche

Reporte zur Charge U007504

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

4Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
WA 1 CA 1 OR 1 WY 1

VAERS 2128345

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U007504

mild
Staat
WA
Alter
4,0
Geschlecht
M
Eingang
19.02.2022
Impfdatum
18.02.2022
Beginn
18.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site swelling Weight bearing difficulty

Symptomtext

Developed pain of right thigh the evening after the injection. Was not putting weight on the right leg. The next morning there was thigh swollen and erythematous. Right thigh was 14 inch diameter, left thigh 13 inches diameter. 2cmx5 cm area of redness on skin. When patient seen in clinic 2/19 (the following day), patient was weight bearing and jumping around. Suspect it to be a large local reaction developing. Dtap #5, IPV #4 (first Kinrix) MMR#2, Varicella #2 (first Proquad)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
No lab tests.
Aktuelle Erkrankungen
Felt like there was "hair in his throat". Normal exam.
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2471239

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U007504

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
07.10.2022
Impfdatum
07.09.2022
Beginn
07.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported.; expired dose of PROQUAD was administered to a patient on 7SEP2022; This spontaneous report was received from medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 07-SEP-2022, the patient was vaccinated with expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) recombinant human albumin (rHA) subcutaneous injection, 0.5 ml, for prophylaxis (anatomical location, and route of administration were not provided), lot # U007504 has been verified to be a valid lot number for measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA), expiration date upon internal validation established as 04-SEP-2022 (the same as reported) (expired product administered). Administered vaccine measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) was not involved in temperature excursion through the date of administration. There were no adverse events reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2430071

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge u007504

gering
Staat
OR
Alter
4,0
Geschlecht
M
Eingang
06.09.2022
Impfdatum
06.09.2022
Beginn
06.09.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Expired vaccine administered to patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2410187

GLAXOSMITHKLINE BIOLOGICALS · DTAP + IPV (KINRIX) · Charge U007504

gering
Staat
WY
Alter
2,0
Geschlecht
M
Eingang
12.08.2022
Impfdatum
12.08.2022
Beginn
12.08.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration No adverse event

Symptomtext

The vaccine was given out of the recommended schedule. Patient was monitored for a period of time. No adverse events resulted

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
none
Vorgeschichte
Cognitive malformation syndrome Global developmental delay
Andere Medikamente
vigavatrin, gabapentin, baclosen
Allergien
none
Vorherige Impfungen
-